Cargando…
The Role of Cost-Effectiveness Analysis in Patient-Centered Cancer Care in the Era of Precision Medicine
Autores principales: | Toscano, Fabrizio, Vera, Alberto, Kim, Eleanor, Golinelli, Davide, Vila-Reyes, Helena, Bteich, Fernand, Schernberg, Antoine, Seban, Romain-David, Yeh, Randy, Dercle, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428334/ https://www.ncbi.nlm.nih.gov/pubmed/34503082 http://dx.doi.org/10.3390/cancers13174272 |
Ejemplares similares
-
Editorial: Breakthrough in Imaging-Guided Precision Medicine in Oncology
por: Shaw, Ashley, et al.
Publicado: (2022) -
Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?
por: Seban, Romain-David, et al.
Publicado: (2021) -
Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy
por: Seban, Romain-David, et al.
Publicado: (2019) -
Advances in PET/CT Imaging for Breast Cancer Patients and Beyond
por: Khalil, David, et al.
Publicado: (2023) -
The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma
por: Girard, Antoine, et al.
Publicado: (2020)